ArticleScientific reports2026
Influence of nicotine concentration and flavours on mouth level exposure and puffing topography among regular e-cigarette consumers in New Zealand.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
E-cigarette aerosols have substantially reduced toxicant profiles relative to cigarette smoke. Consumers' actual exposure is influenced by the way in which they use these products. We have assessed whether consumer puffing topography (e.g., puff duration, volume and frequency), mouth level exposure (MLE) to nicotine and aerosol, or average daily consumption (ADC) are affected by nicotine concentration or flavour. The study was conducted in New Zealand in 2023 among 90 adult e-cigarette users. Puffing topography and MLE were measured for eight e-liquid variants (five nicotine levels, four flavours) in (1) 15-minute vaping sessions during central location testing (CLT); and (2) 7-day home use testing (HUT). The CLT estimated MLE to nicotine increased with increasing concentration of nicotine, while MLE to aerosol decreased, puff duration decreased and interpuff interval increased, indicating that users alter puffing behaviour to achieve a preferred level of nicotine. Results from the HUT supported these findings. In CLT, less acceptable flavours (e.g., Golden Tobacco) led to significantly fewer puffs of shorter duration compared with more acceptable flavours (e.g., Crisp Mint and Tropical Mango). When the participants used their preferred flavour in HUT, there were no differences in MLE per day or ADC among flavours. E-cigarette users maintain a preferred level of nicotine exposure per day by altering the duration and number of puffs taken in response to nicotine concentration. Overall liking of a flavour is likely to be important in providing a satisfactory alternative to continued smoking for smokers who would not otherwise quit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.